CD8A and colorectal cancer: In addition, Zhang H. et al. [19] showed that the DNase I enzyme, which degrades NETs, diminished the resistance to PD-1 blockade by increasing CD8+ T-cell infiltration and cytotoxicity in a mouse colorectal cancer model.